Skip to content

Endometrial Cancer

by Kimberly K. Leslie, Kristina W. Thiel, Michael J. Goodheart, Koen De Geest, Yichen Jia, Shujie Yang
Obstetrics and Gynecology Clinics of North America ()
Get full text at journal

Abstract

Despite the questions and barriers, the incorporation of molecular therapy into treatment regimens in endometrial cancer is an exciting area of investigation with the potential to improve outcomes. Outside of the development of a reliable screening test for endometrial cancer, converting the disease to a chronic state and improving progression-free survival is our best hope to reverse the concerning trend of decreasing 5-year survival for this disease.

Cite this document (BETA)

Readership Statistics

11 Readers on Mendeley
by Discipline
 
82% Medicine and Dentistry
 
18% Agricultural and Biological Sciences
by Academic Status
 
27% Researcher
 
18% Student > Master
 
18% Student > Postgraduate

Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Sign up & Download

Already have an account? Sign in